Logo

Condensed financial statements

Consolidated income statement

EUR million Q2 2026 Q2 2025 6M 2026 6M 2025 LTM FY 2025
Revenue 640.4 596.7 1,264.6 1,174.8 2,467.9 2,378.1
Operating expenses            
Medical provision costs -486.7 -454.6 -963.7 -900.0 -1,891.1 -1,827.4
Gross profit 153.7 142.1 300.9 274.8 576.8 550.7
Distribution, selling and marketing costs -29.4 -27.2 -58.9 -54.2 -111.3 -106.6
Administrative costs -73.1 -73.2 -144.1 -142.9 -289.6 -288.4
Operating profit (EBIT) 51.2 41.7 97.9 77.7 175.9 155.7
Other income/(costs) -0.1 1.6 -0.1 1.8 -0.3 1.6
Interest income 1.3 1.0 2.3 2.0 4.6 4.3
Interest expense -16.6 -16.5 -33.2 -31.7 -65.5 -64.0
Other financial income/(expense) -2.6 -3.0 -5.1 1.1 -5.5 0.7
Total financial result -17.9 -18.5 -36.0 -28.6 -66.4 -59.0
Share of profit of associates 0.0 0.2 0.0 0.2 -0.1 0.1
Profit before income tax 33.2 25.0 61.8 51.1 109.1 98.4
Income tax -9.3 -7.0 -17.3 -14.3 -28.7 -25.7
Profit for the period 23.9 18.0 44.5 36.8 80.4 72.7
             
Profit attributable to:            
Owners of the parent 24.5 19.1 46.6 39.2 84.9 77.5
Non-controlling interests -0.6 -1.1 -2.1 -2.4 -4.5 -4.8
Profit for the period 23.9 18.0 44.5 36.8 80.4 72.7
             
Earnings per share:            
Basic, € 0.161 0.127 0.308 0.261 0.561 0.514
Diluted, € 0.161 0.127 0.306 0.260 0.560 0.513

 

Loading...